Marianne Farnebo

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 3

Top Topics

Top Venues

Science advances

Nature communications

Molecular oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Moa Egelberg, Tommaso De Marchi, Gyula Pekar, Lena Tran, Pär-Ola Bendahl, Axel Stenmark Tullberg, Erik Carl Viktor Holmberg, Per Karsson, Marianne Farnebo, Fredrika Killander, Emma Nimeús
Low levels of WRAP53 predict decreased efficacy of radiotherapy and are prognostic for local recurrence and death from breast cancer: a long-term follow-up of the SweBCG91RT randomized trial. Molecular oncology (2023)
Chiara Pederiva, Davide M Trevisan, Dimitra Peirasmaki, Shan Chen, Sharon A Savage, Ola Larsson, Jernej Ule, Laura Baranello, Federico Agostini, Marianne Farnebo
Control of protein synthesis through mRNA pseudouridylation by dyskerin. Science advances 9 (30) (2023)
Sofie Bergstrand, Eleanor M O'Roberts, Christos Coucoravas, Dominika Hrossova, Dimitra Peirasmaki, Sandro Schmidli, Soniya Dhanjal, Chiara Pederiva, Lee Siggens, Oliver Mortusewicz, Julienne J O'Rourke, Marianne Farnebo
Small Cajal body-associated RNA 2 (scaRNA2) regulates DNA repair pathway choice by inhibiting DNA-PK. Nature communications 13 (1) (2022)